About Remedium Bio
Remedium Bio is a private company based in Needham, Massachusetts. It has reported $5,934,955 raised in two offerings on Form D since November 2021. Its chief executive is Frank Luppino.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 6, 2026 | May 18, 2026 | $1,500,000of $10.0M target | 1 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Nov 5, 2021 | Nov 9, 2021amended Aug 28, 2024 | $4,434,955of $7.2M target | 26 | $170K | Debt, SAFERule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $5,934,955 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Remedium Bio's Form D filed May 18, 2026.
Earlier filings also listed Luppino Francesco (executive officer and director, last listed Aug 2024).